QQ客服 官方微博 反馈留言

	Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
	Wu, Kai-Chun[1]; Ran, Zhi Hua[2]; Gao, Xiang[3]; Chen, Minhu[4]; Zhong, Jie[5]; Sheng, Jian-Qiu[6]; Kamm, Michael A.[7,8,9]; Travis, Simon[10]; Wallace, Kori[11]; Mostafa, Nael M.[11]
刊名	INTESTINAL RESEARCH
	2016
卷号	14页码:152-163
关键词	Crohn disease Anti-tumor necrosis factor Adalimumab
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2195061
专题	华南理工大学
作者单位	1.[1]Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China 2.[2]Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China 3.[3]Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China 4.[4]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 5.[5]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China 6.[6]PLA, Mil Gen Hosp Beijing, Beijing, Peoples R China 7.[7]St Vincents Hosp, Melbourne, Vic, Australia 8.[8]Univ Melbourne, Melbourne, Vic, Australia 9.[9]Imperial Coll, London, England 10.[10]Translat Gastroenterol Unit, Oxford, England
推荐引用方式 GB/T 7714	Wu, Kai-Chun[1],Ran, Zhi Hua[2],Gao, Xiang[3],et al. Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease[J]. INTESTINAL RESEARCH,2016,14:152-163.
APA	Wu, Kai-Chun[1].,Ran, Zhi Hua[2].,Gao, Xiang[3].,Chen, Minhu[4].,Zhong, Jie[5].,...&Robinson, Anne M.[11].(2016).Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease.INTESTINAL RESEARCH,14,152-163.
MLA	Wu, Kai-Chun[1],et al."Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease".INTESTINAL RESEARCH 14(2016):152-163.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。